IRIS
SANTINI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.936
NA - Nord America 3.180
EU - Europa 1.507
OC - Oceania 66
AF - Africa 39
SA - Sud America 39
AN - Antartide 1
Totale 9.768
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.076
SG - Singapore 3.010
HK - Hong Kong 975
GB - Regno Unito 703
CN - Cina 672
IT - Italia 292
DE - Germania 163
IN - India 124
CA - Canada 94
AU - Australia 64
NL - Olanda 63
UA - Ucraina 46
FI - Finlandia 33
CZ - Repubblica Ceca 32
TR - Turchia 32
FR - Francia 31
JP - Giappone 31
ZA - Sudafrica 30
ID - Indonesia 22
BR - Brasile 21
BE - Belgio 17
EE - Estonia 17
KR - Corea 15
ES - Italia 11
RU - Federazione Russa 11
CH - Svizzera 10
SA - Arabia Saudita 9
MX - Messico 7
PL - Polonia 7
TW - Taiwan 7
AR - Argentina 6
AT - Austria 6
HU - Ungheria 6
IL - Israele 6
PT - Portogallo 6
SE - Svezia 6
SK - Slovacchia (Repubblica Slovacca) 6
EG - Egitto 5
GR - Grecia 5
PE - Perù 5
RO - Romania 5
SI - Slovenia 5
CL - Cile 4
LU - Lussemburgo 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
HR - Croazia 3
KW - Kuwait 3
NG - Nigeria 3
PH - Filippine 3
PK - Pakistan 3
TH - Thailandia 3
VN - Vietnam 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CY - Cipro 2
IE - Irlanda 2
IQ - Iraq 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
BD - Bangladesh 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
JM - Giamaica 1
JO - Giordania 1
LT - Lituania 1
MD - Moldavia 1
MS - Montserrat 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
SL - Sierra Leone 1
YE - Yemen 1
Totale 9.768
Salva come PNG Salva come JPEG
Città #
Singapore 1.220
Hong Kong 957
Ashburn 953
Boardman 801
London 651
Shanghai 478
San Francisco 136
Pune 102
Seattle 96
Los Angeles 93
Toronto 85
Council Bluffs 72
Washington 66
Rome 54
Santa Clara 42
Helsinki 33
Melbourne 32
Amsterdam 30
Brno 29
Munich 20
Naples 20
Tokyo 19
Canberra 16
Sydney 16
West Jordan 16
Milan 13
New York 13
Paris 13
Hanover 12
Hasselt 12
Secaucus 11
St Louis 11
Haikou 10
São Paulo 10
Riyadh 9
Chicago 8
Hyderabad 8
Guangzhou 7
Markham 7
Oklahoma City 7
Redmond 7
Sona 7
Bologna 6
Central 6
Frankfurt am Main 6
Mong Kok 6
Palermo 6
Vienna 6
Warsaw 6
Baoding 5
Bratislava 5
Florence 5
Lima 5
Ljubljana 5
New Taipei 5
San Pietro in Lama 5
Yeonsu-gu 5
Beijing 4
Brooklyn 4
Budapest 4
Crawley 4
Haifa 4
Handan 4
Lincoln 4
Luxembourg 4
Padova 4
Reston 4
San Ferdinando Di Puglia 4
Shijiazhuang 4
Wuhan 4
Andover 3
Antwerp 3
Athens 3
Barcelona 3
Brussels 3
Centurion 3
Changsha 3
Durham 3
Ferrara di Monte Baldo 3
Gangseo-gu 3
Johannesburg 3
Kuwait City 3
Lakewood 3
Linyi 3
Madrid 3
Mexico City 3
Miami 3
Modena 3
Monza 3
Ningbo 3
Perugia 3
Pescara 3
Porto 3
San Nicola Manfredi 3
Sarajevo 3
Tirana 3
Zhengzhou 3
Abuja 2
Alba 2
Anyang 2
Totale 6.423
Salva come PNG Salva come JPEG
Nome #
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 49
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 39
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 36
Skeletal alkaline phosphatase as a serum marker of bone metastases in the follow-up of patients with breast cancer 35
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis. 34
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 32
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 31
What can we learn from the ZOOM trial? Reply 31
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 30
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 30
Early impairment of food intake in patients newly diagnosed with cancer 29
Anestesia e malattie non comuni 29
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 29
A giant sarcoma of the parotid gland: A case report and review of the literature 28
Classic Kaposi Sarcoma: to treat or not to treat? 28
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 28
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 28
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 28
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 28
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 28
'Old' and 'new' drugs for the treatment of cancer pain 28
Role of c-mesenchymal-epithelial transition pathway in gastric cancer 28
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 27
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD) 27
Premetastatic niche: ready for new therapeutic interventions? 27
Biological effects of cabozantinib on bone microenvironment 27
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 26
Uncommon EGFR mutations in non-small-cell lung cancer 26
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 26
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 26
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 26
Erratum: Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients (British Journal of Cancer (2005) 92 (2225-2232) DOI: 10.1038/sj.bjc.6602632) 26
Colorectal carcinomas and PTEN/MMAC1 gene mutations 25
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 25
Esperienza della Libera Università Campus Bio-Medico sui sistemi Port-A-Cath venosi in oncologia 25
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 25
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 25
Ineffective target therapy in non-small cell lung cancer harboring BRAF G466R mutation: a case report and biological rationale 24
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 24
New perspectives: role of Sunitinib in breast cancer 24
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 24
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 24
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 24
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 24
PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline-based first line therapy 23
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 23
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 23
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 23
Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives 23
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 23
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 23
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 23
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 23
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 23
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 23
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 22
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 22
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 22
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 22
A key opinion leader interview with Prof D Santini: insight into cancer research. 22
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 22
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience 22
Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer 22
hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma 22
Molecular prognostic factors in patients with pancreatic cancer 22
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 22
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 22
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 22
Atypical chronic head and neck pain: don't forget Eagle's syndrome 22
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 22
Designing a broad-spectrum integrative approach for cancer prevention and treatment 22
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 21
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 21
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 21
Docetaxel induced pericardial effusion 21
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 21
Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients 21
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 21
Denosumab for cancer-related bone loss 21
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 21
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 21
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) 21
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients 20
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? 20
Idiosyncratic reaction after oxaliplatin infusion 20
Cutting the Limits of Aminobisphosphonates: New Strategies for the Potentiation of their Anti-Tumour Effects 20
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 20
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 20
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 20
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 20
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control Study 20
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 20
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer 20
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis? 20
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome 20
Bone Health in Cancer Patients 20
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 20
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial 20
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 20
Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and outcomes with nivolumab in pretreated Non-Small Cell Lung Cancer (NSCLC): a large retrospective multicenter study 20
Totale 2.439
Salva come PNG Salva come JPEG
Categoria #
all - tutte 217.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 217.481
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.010 0 4 5 8 73 10 15 4 42 20 23 806
2022/2023203 18 7 3 13 16 7 18 20 9 3 80 9
2023/20242.297 52 281 95 171 239 1.039 17 154 23 59 75 92
2024/20256.391 335 274 924 147 171 511 315 63 1.959 1.581 111 0
Totale 9.901